Literature DB >> 11903225

Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer.

S H Ibbotson1.   

Abstract

Topical 5-aminolaevulinic acid (ALA) photodynamic therapy (PDT) is used increasingly for superficial non-melanoma skin cancer (NMSC) and dysplasia. However, the relative accumulation of the photosensitizer protoporphyrin IX (PpIX) in diseased tissue is not specific for neoplastic disease, and has been shown after the application of ALA to benign proliferative skin conditions such as viral warts and psoriasis. This review appraises the quality of evidence available for the use of topical ALA-PDT in the treatment of skin conditions other than NMSC. The diseases that have been studied in most detail are recalcitrant viral warts, acne, psoriasis and cutaneous T-cell lymphoma. Publications relating to the treatment of other diseases by topical PDT are restricted to small case series or case reports. The relevant literature will be discussed and the potential for topical PDT in the treatment of several skin diseases is highlighted, although more detailed studies are required to clarify the role of PDT beyond the treatment of NMSC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11903225     DOI: 10.1046/j.0007-0963.2001.04689.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

Review 1.  Oily Skin: A review of Treatment Options.

Authors:  Dawnielle C Endly; Richard A Miller
Journal:  J Clin Aesthet Dermatol       Date:  2017-08-01

Review 2.  Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.

Authors:  M Lam; A H Hsia; Y Liu; M Guo; A R Swick; J C Berlin; T S McCormick; M E Kenney; N L Oleinick; K D Cooper; E D Baron
Journal:  Clin Exp Dermatol       Date:  2011-05-30       Impact factor: 3.470

3.  Bystander effects induced by diffusing mediators after photodynamic stress.

Authors:  Asima Chakraborty; Kathryn D Held; Kevin M Prise; Howard L Liber; Robert W Redmond
Journal:  Radiat Res       Date:  2009-07       Impact factor: 2.841

4.  Vitamin D Combined with Aminolevulinate (ALA)-Mediated Photodynamic Therapy (PDT) for Human Psoriasis: A Proof-of-Principle Study.

Authors:  Edward V Maytin; Golara Honari; Amor Khachemoune; Charles R Taylor; Bernhard Ortel; Brian W Pogue; Nathaniel Sznycer-Taub; Tayyaba Hasan
Journal:  Isr J Chem       Date:  2012-08-21       Impact factor: 3.333

5.  Cutaneous penetration of the topically applied photosensitizer Pc 4 as detected by intravital 2-photon laser scanning microscopy.

Authors:  Alex Y Huang; Jay T Myers; Deborah Barkauskas; Scott J Howell; Nancy L Oleinick; Thomas S McCormick; Kevin D Cooper; Elma D Baron; Minh Lam
Journal:  Photodiagnosis Photodyn Ther       Date:  2012-02-23       Impact factor: 3.631

6.  Efficiency of photodynamic therapy in the treatment of diffuse facial viral warts in an immunosuppressed patient: towards a gold standard?

Authors:  M Caucanas; P Gillard; O Vanhooteghem
Journal:  Case Rep Dermatol       Date:  2010-12-29

Review 7.  The evolution of clinical guidelines for antimicrobial photodynamic therapy of skin.

Authors:  Alison M Mackay
Journal:  Photochem Photobiol Sci       Date:  2022-02-07       Impact factor: 4.328

8.  Graphene Oxide Topical Administration: Skin Permeability Studies.

Authors:  Filipa A L S Silva; Raquel Costa-Almeida; Licínia Timochenco; Sara I Amaral; Soraia Pinto; Inês C Gonçalves; José R Fernandes; Fernão D Magalhães; Bruno Sarmento; Artur M Pinto
Journal:  Materials (Basel)       Date:  2021-05-25       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.